その他, その他, 細胞・免疫療法

ライフサイエンス, 血液、腫瘍内科学, CAR-T療法

Frequency and clinical impact of acute kidney injury in haploidentical hematopoietic cell transplantation with post-transplantation cyclophosphamide.
Toshihide Endo; Hiromichi Takahashi; Takahiro Namiki; Yoshiyuki Hayashi; Shun Ito; Hironao Nukariya; Kazuya Kurihara; Takashi Koike; Yuuichi Takeuchi; Takashi Hamada; Kazuhide Iizuka; Shimon Otake; Masaru Nakagawa; Hideki Nakamura; Katsuhiro Miura
Leukemia research, 2025年11月

Role of Daratumumab, Lenalidomide, and Dexamethasone in Transplantation-Eligible Patients with Multiple Myeloma After the Failure of Bortezomib-Based Induction Therapy.
Shun Ito; Takashi Hamada; Masaru Nakagawa; Takashi Ichinohe; Hironao Nukariya; Toshihide Endo; Kazuya Kurihara; Yuichi Takeuchi; Shimon Otake; Hiromichi Takahashi; Hideki Nakamura; Katsuhiro Miura
Hematology reports, 2025年10月

The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience.
Noriyoshi Iriyama; Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Shimon Otake; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Hideki Nakamura
Journal of clinical and experimental hematopathology : JCEH, 2025年05月

Contemporary management of diffuse large B-cell lymphoma in Japan.
Katsuhiro Miura; Hiromichi Takahashi; Haruna Nishimaki-Watanabe; Takashi Hamada; Akihiro Uchiike; Daisuke Tsutsumi; Shimon Ohtake; Kazuhide Iizuka; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tatsuya Hayama; Masaru Nakagawa; Noriyoshi Iriyama; Yoshihiro Hatta; Hideki Nakamura
Expert review of anticancer therapy, 2025年05月

Topological importance of CD8+ T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma
Hiromichi Takahashi; Shun Ito; Yoko Nakanishi; Katsuhiro Miura; Haruna Nishimaki; Masaru Nakagawa; Shimon Otake; Takashi Hamada; Takashi Koike; Kazuhide Iizuka; Shinobu Masuda; Tomohiro Nakayama; Tetsuo Shimizu; Naoya Ishibashi; Hirofumi Kogure; Hideki Nakamura
Annals of Hematology, 2025年01月

Brentuximab vedotin monotherapy for CD30-positive adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells.
Shun Ito; Hiromichi Takahashi; Haruna Watanabe-Nishimaki; Kennosuke Karube; Takahiro Namiki; Takashi Hamada; Shimon Otake; Katsuhiro Miura; Hideki Nakamura
Journal of clinical and experimental hematopathology : JCEH, 2025年

Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers' polycythemia and polycythemia vera.
Kazuhide Iizuka; Yoshikazu Iizuka; Shun Ito; Toshihide Endo; Hironao Nukariya; Yuichi Takeuchi; Takashi Koike; Kazuya Kurihara; Hiromichi Takahashi; Masaru Nakagawa; Takashi Hamada; Shimon Ohtake; Noriyoshi Iriyama; Katsuhiro Miura; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura; Norio Komatsu
PloS one, 2025年

TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly
Katsuhiro Miura; Haruna Nishimaki-Watanabe; Hiromichi Takahashi; Masaru Nakagawa; Shimon Otake; Takashi Hamada; Takashi Koike; Kazuhide Iizuka; Yuuichi Takeuchi; Kazuya Kurihara; Toshihide Endo; Shun Ito; Hironao Nukariya; Takahiro Namiki; Yoshiyuki Hayashi; Hideki Nakamura
Biomedicines, 2024年06月

Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation
Takashi Hamada; Hiromichi Takahashi; Masaru Nakagawa; Hironao Nukariya; Shun Ito; Toshihide Endo; Kazuya Kurihara; Takashi Koike; Kazuhide Iizuka; Shimon Ohtake; Takashi Ichinohe; Toshiya Maebayashi; Katsuhiro Miura; Yoshihiro Hatta; Hideki Nakamura
Case Reports in Oncology, 2023年05月

臨床血液
Shuhei Matsumoto; Hiromichi Takahashi; Takashi Hamada; Katsuhiro Miura; Masaru Nakagwa; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Kazuhide Iizuka; Noriyoshi Iriyama; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
臨床血液The Japanese journal of clinical hematology 64(4) 255-259 2023.4, 2023年, 査読有り, 通常論文

Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience
Noriyoshi Iriyama; Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
Leukemia & Lymphoma, 2022年10月

Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study
Hiromichi Takahashi; Katsuhiro Miura; Masaru Nakagawa; Haruna Nishimaki; Shun Ito; Hironao Nukariya; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Takashi Hamada; Kazuhide Iizuka; Shimon Ohatake; Noriyoshi Iriyama; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
Hematological Oncology, 2022年07月

Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma
Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Takashi Hamada; Yoshihito Uchino; Kazuhide Iizuka; Shimon Ohtake; Noriyoshi Iriyama; Yoshihiro Hatta; Hideki Nakamura
Expert Review of Anticancer Therapy, 2022年05月

Clinical impact of central nervous system‐directed therapies on intravascular large B‐cell lymphoma: A single institution's experience
Hiromichi Takahashi; Haruna Nishimaki; Yoko Nakanishi; Takashi Hamada; Masaru Nakagawa; Kazuhide Iizuka; Yoshihito Uchino; Noriyoshi Iriyama; Katsuhiro Miura; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
eJHaem, 2022年02月

Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.
Noriyoshi Iriyama; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Tomohiro Nakayama; Masami Takei; Yoshihiro Hatta; Hideki Nakamura
Chemotherapy, 2021年11月

Absolute Lymphocyte Counts After Lenalidomide Initiation may Predict the Prognosis of Patients With Relapsed or Refractory Multiple Myeloma
MASARU NAKAGAWA; NORIYOSHI IRIYAMA; TAKUTO ISHIKAWA; KATSUHIRO MIURA; YOSHIHITO UCHINO; HIROMICHI TAKAHASHI; TAKASHI HAMADA; KAZUHIDE IIZUKA; TAKASHI KOIKE; KAZUYA KURIHARA; TOMOHIRO NAKAYAMA; YOSHIHIRO HATTA; MASAMI TAKEI
Cancer Diagnosis & Prognosis, 2021年07月

[Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma].
Takashi Koike; Noriyoshi Iriyama; Masaru Nakagawa; Hiromichi Takahashi; Takashi Hamada; Yoshihito Uchino; Katsuhiro Miura; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2020年

A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
Noriyoshi Iriyama; Hiromichi Takahashi; Hiromu Naruse; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
Molecular genetics & genomic medicine, 2019年04月, 査読有り, 通常論文

[Achievement of a stringent complete response with low-dose pomalidomide monotherapy in a multiple myeloma patient].
Toshihide Endo; Takashi Hamada; Shimon Otake; Masaru Nakagawa; Yshihito Uchino; Hiromichi Takahashi; Katsuhiro Miura; Noriyoshi Iriyama; Takashi Koike; Kazuya Kurihara; Hiroko Sato; Yoshihiro Hatta; Msamai Takei
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2018年

右心房を占拠する巨大節外病変で労作時呼吸困難を呈したびまん性大細胞型B細胞性リンパ腫(DLBCL)
一戸崇; 大竹志門; 伊藤駿; 三浦勝浩; 高橋宏通; 中川優; 濱田高志; 小池隆; 遠藤聖英; 栗原一也; 忽滑谷寛直
臨床血液, 2024年

★B細胞性急性リンパ芽球性白血病における新規融合遺伝子ZNF362::MAML3の同定と機能解析
Takashi Hamada; Makoto Makishima; Michiyasu Ishizawa; Kaori EndoUmeda; Shimon Otake; Masaru Nakagawa; Hiromichi Takahashi; Yoshihito Uchino; Katsuhiro Miura; Hideki Nakamura
第86回日本血液学会学術総会, 2024年10月, 通常論文

新規 3-way 染色体転座のt(8;11;14) を有する骨髄腫の一例
Takashi Hamada; Masaru Nakagawa; Shun Ito; Takashi Koike; Shimon Otake; Hiromichi Takahashi; Noriaki Takahashi; Katsuhiro Miura; Hideki Nakamura
第49回日本骨髄腫学会学術集会, 2024年06月, 通常論文

2016年05月 - 現在
日本造血・免疫細胞療法学会

2015年04月 - 現在
日本内科学会

2023年12月
日本骨髄腫学会

2016年11月
日本血液学会